Skip to main content
Premium Trial:

Request an Annual Quote

Envisagenics Awarded $300K NCI Grant to Refine Drug Discovery Tech

NEW YORK — Envisagenics said today that it has received a $300,000 grant from the National Cancer Institute to refine its cloud-based RNA splicing analytics platform for the discovery of novel immuno-oncology therapeutics.

The platform, called SpliceCore, is designed to map patient RNA sequencing datasets to a collection of over 5 million alternative splicing errors in order to pinpoint ones that cause disease. Machine learning algorithms are then used to prioritize druggable splicing events and identify novel RNA-based drugs.

With the one-year, Phase I Small Business Innovation Research (SBIR) grant, Evisagenics will collaborate with researchers at Memorial Sloan Kettering Cancer Center to adapt SpliceCore for the identification of splicing-dependent tumor-associated ectodomains that may serve as drug targets or diagnostic biomarkers. Envisagenics said the investigators will initially focus on acute myeloid leukemia, but that the approach could potentially be used in other cancers and inflammatory diseases. 

Envisagenics won a $225,000 Phase I SBIR grant to create a prototype of SpliceCore in 2015 and received a $1.5 million Phase II SBIR grant three years later to further develop the platform. Since then, the New York City-based company has used the technology to identify its first preclinical drug candidate, which it said targets a novel isoform present in 65 percent of triple negative breast cancers.

Envisagenics closed a $2.4 million seed financing round in late 2017.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.